Teratoma future or investigational therapies
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Use in basic research
Use in basic research
In light of the ethical issues surrounding the source of human stem cells, teratomas are being looked at as an alternative source for research since they lack the potential to grow into functional human beings.
Clinical trials
Clinical trials
There are now (2007) two clinical trials in progress that address germ cell tumors, both of which include teratomas.[1][2]
References
References
- ↑ GCT1P1 Protocol / Clinical Study: Pilot study of Cisplatin, Etoposide, Bleomycin and Escalating Dose Cyclophosphamide Therapy for Children with High-Risk Malignant Germ Cell Tumors
- ↑ GCT132 Protocol / Clinical Study: A Phase III Study of Reduced Therapy in the Treatment of Children with Low and Intermediate Risk Extracranial Germ Cell Tumors (AGCT0132)
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
